Literature DB >> 7857879

Lignan and isoflavonoid conjugates in human urine.

H Adlercreutz1, J van der Wildt, J Kinzel, H Attalla, K Wähälä, T Mäkelä, T Hase, T Fotsis.   

Abstract

Lignans and isoflavonoids are two groups of diphenolic phytoestrogens of plant origin which have gained increasing interest because of their possible cancer protective properties. High excretion of these compounds occur in populations at low risk of breast, prostate and colon cancer consuming either high amounts of whole-grain (lignans and some isoflavonoids) or soy products (isoflavonoids and some lignans). We determined the pattern of conjugation of the phytoestrogens in four urine samples from vegetarian or semivegetarian women and in two samples from men. Seven compounds were investigated: enterodiol, enterolactone, matairesinol, diadzein, equol, genistein and O-desmethylangolensin. The fractions quantified are the free fraction, mono- and disulfate, as well as the mono-, di- and sulfoglucuronide fractions. For the fractionation and purification we used ion-exchange chromatography and the determination of the concentrations of each compound in all fractions was done by isotope dilution gas chromatography-mass spectrometry (GLC-MS) using deuterated internal standards of all diphenols. More than 60% of all compounds determined, occurred in the monoglucuronide fraction. Daidzein, enterodiol and equol are excreted to a relatively high extent as sulfoglucuronides and genistein as diglucuronide. We conclude that the general pattern of lignan and isoflavonoid conjugates in urine is similar to that of endogenous estrogens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7857879     DOI: 10.1016/0960-0760(94)00146-d

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  20 in total

1.  Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells.

Authors:  Li-Hua Chen; Jing Fang; Zhijian Sun; Huaixing Li; Ying Wu; Wendy Demark-Wahnefried; Xu Lin
Journal:  J Nutr       Date:  2009-02-11       Impact factor: 4.798

Review 2.  Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives.

Authors:  Aniket V Mali; Subhash B Padhye; Shrikant Anant; Mahabaleshwar V Hegde; Shivajirao S Kadam
Journal:  Eur J Pharmacol       Date:  2019-02-14       Impact factor: 4.432

3.  Plasma metabolite abundances are associated with urinary enterolactone excretion in healthy participants on controlled diets.

Authors:  Fayth L Miles; Sandi L Navarro; Yvonne Schwarz; Haiwei Gu; Danijel Djukovic; Timothy W Randolph; Ali Shojaie; Mario Kratz; Meredith A J Hullar; Paul D Lampe; Marian L Neuhouser; Daniel Raftery; Johanna W Lampe
Journal:  Food Funct       Date:  2017-09-20       Impact factor: 5.396

4.  Production of sesaminol and antioxidative activity of fermented sesame with Lactobacillus plantarum P8, Lactobacillus acidophilus ATCC 4356, Streptococcus thermophilus S10.

Authors:  Jin-Ju Bae; Su-Jung Yeon; Woo-Joon Park; Go-Eun Hong; Chi-Ho Lee
Journal:  Food Sci Biotechnol       Date:  2016-02-29       Impact factor: 2.391

5.  Suitability of a batch in vitro fermentation model using human faecal microbiota for prediction of conversion of flaxseed lignans to enterolactone with reference to an in vivo rat model.

Authors:  Anna-Marja Aura; Seija Oikarinen; Marja Mutanen; Satu-Maarit Heinonen; Herman C T Adlercreutz; Hannele Virtanen; Kaisa S Poutanen
Journal:  Eur J Nutr       Date:  2005-04-25       Impact factor: 5.614

Review 6.  Dietary lignans: physiology and potential for cardiovascular disease risk reduction.

Authors:  Julia Peterson; Johanna Dwyer; Herman Adlercreutz; Augustin Scalbert; Paul Jacques; Marjorie L McCullough
Journal:  Nutr Rev       Date:  2010-10       Impact factor: 7.110

7.  Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.

Authors:  Ajita V Singh; Adrian A Franke; George L Blackburn; Jin-Rong Zhou
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

8.  Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers.

Authors:  Wen-Xing Peng; Huan-De Li; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2003-05-17       Impact factor: 2.953

Review 9.  O-desmethylangolensin: the importance of equol's lesser known cousin to human health.

Authors:  Cara L Frankenfeld
Journal:  Adv Nutr       Date:  2011-06-28       Impact factor: 8.701

Review 10.  Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME.

Authors:  Zhen Yang; Kaustubh Kulkarni; Wei Zhu; Ming Hu
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.